Comparative effect of thiamphenicol glycinate, thiamphenicol glycinate N-acetylcysteinate, amoxicillin plus clavulanic acid, ceftriaxone and clarithromycin on pulmonary clearance of Haemophilus influenzae in an animal model

Chemotherapy

Volumn 46, Issue 4, 2000, Pages 275-281

  Drago, Lorenzo ^a   Fassina, Maria Cristina ^b   Mombelli, Barbara ^b   De Vecchi, Elena ^b   Lombardi, Alessandra ^b   Gismondo, Maria Rita ^b  

^a LITA VIALBA   (Italy)

^b NONE

Author keywords

Amoxicillin plus clavulanic acid; Ceftriaxone; Clarithromycin; Guinea pigs; Haemophilus influenzae; Thiamphenicol

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFTRIAXONE; CLARITHROMYCIN; THIAMPHENICOL; THIAMPHENICOL GLYCINATE; THIAMPHENICOL GLYCINATE N ACETYLCYSTEINATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; BRONCHUS MUCOSA; CELL KILLING; CONTROLLED STUDY; DRUG EFFECT; GUINEA PIG; HAEMOPHILUS INFLUENZAE; INFLAMMATORY CELL; LUNG CLEARANCE; NONHUMAN; PRIORITY JOURNAL;

EID: 0033943556     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007299     Document Type: Article

References (23)

1. Wallace RJ Jr, Musher DM, Septimus AJ, McGowan JE Jr, Quinones FJ, Wiss K, Vance PH. Trier PA: Haemophilus influenzae infection in adults: Characterization of strains by serotypes, biotypes and β-lactamase production. J Infect Dis 1981; 144:101-106.
2. Cappellelty D: Microbiology of bacterial respiratory infections. Pediatr Infect Dis J 1998;17:S55-S61.
3. Rutman A, Dowling R, Wills P, Feldman C. Cole PJ. Wilson R: Effect of dirithromycin on Heamophilus influenzae infection of the respiratory mucosa. Antimicrob Agent Chemother 1498;42:772-778.
4. Read RC, Wilson R, Rutman A, Lund V. Todd HC, Brain AP, Jeffery PK, Cole PJ: Interaction of nontypable Haemophilus influenzae with human respiratory mucosa in vitro. J Infect Dis 1991;163:549-358.
5. Wallace FJ, Clancy RL, Cripps AW: An animal model demonstration of enhanced clearance of nontypable Haemophilus influenzae from the respiratory tract after antigen stimulation of gut-associated lymphoid tissue. Am Rev Respir Dis 1989; 140;311-316.
6. Hansen EJ, Toews GB: Animal models for the study of noninvasive Haemophilus influenzae disease: Pulmonary clearance systems. J Infect Dis 1992;165:S185-S187.
7. Riise GC. Larsson S, Andersson BA: Bacterial adhesion to oropharyngeal and bronchial epithelial cells in smokers with chronic bronchitis and in healthy non smokers. Eur Respir J 1994;7:1759-1764.
8. Riise GC, Larsson S, Larsson P, Jeansson S, Andersson BA: The intrabronchial microbial flora in chronic bronchitis patients: A target for N-acetylcysteine therapy? Eur Respir J 1994;7:94-101.
9. Albini E, Belluco G, Berton M, Schioppacassi G, Ungheri D: In vitro antibacterial activity of thiamphenicol glycinate acetylcysteinate against respiratory pathogens. Arzneimittelforschung 1999;49:533-537.
10. Neu HC, Fu PK: In vitro activity of chloramphenicol and thiamphenicol analogs. Antimicrob Agents Chemother 1980;18:311-316.
11. Mayaud C, Lentschner C, Bouchoucha S, Marsac J: L'acétylcystéinate do thiamphénicol glycinate dans le traitement des infections respiratoires aiguës avec mucostase. Eur J Respir Dis 1980;111 (suppl):70-73.
12. Eklund A, Eriksson O, Hakansson K, Larsson K, Ohlsson K, Venge P, Bergstrand H, Bjornson A, Brattsand R, Glennow C, Linden M, Wieslander E: Oral N-acetylcysteine reduces selected humoral markers of inflammatory cell activity in BAL fluid from healthy smokers: Correlation to effects on cellular variables. Eur Respir J 1988;1:832-838.
13. Rasmussen JB, Glennow C: Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis. Eur Resp J 1988;1:351-355.
14. Boman G, Backer U, Larsson S, Melander B, Wahlander L: Oral acelylcysteine reduces exacerbation rate in chronic bronchitis: Report of a trial organized by the Swedish Society for Pulmonary Diseases. Eur J Respir Dis 1983;64:405-415.
15. Olivieri D, Marsico SA, Del Donno M: Improvement of mucociliary transport in smokers by mucolytics. Eur J Respir Dis 1985;139(suppl): 142-145.
16. Fossati C: Sull'impiego di un nuovo mucolitico da solo od associate ad un antibiotico nel trattamento delle affezioni bronco-pleuro-polmonari. Clin Ter 1968;44:221-242.
17. Anonymous: Haemophilus influenzae invasive disease among children aged < 5 years - California, 1990-1996. JAMA 1998;280:1130-1131.
18. Foxwell AR, Kyd JM, Cripps AW: Nontypeable Haemophilus influenzae: Pathogenesis and prevention. Microbiol Mol Biol Rev 1998;62: 294-308.
19. Gorter AD, EiJk PP, van Wetering S. Hiemstra PS, Danken J, van Alphen L: Stimulation of the adherence of Haemophilus influenzae to human lung epithelial cells by antimicrobial neutrophils defensins. J Infect Dis 1998;178:1067-1074.
20. Ketterer MR. Shao JQ, Hornick DB, Buscer B, Bandi VK, Apicella MA: Infection of primary human bronchial epithelial cells by Haemophilus influenzae. Macropinocytosis as a mechanism of airway epithelial cell entry. Infect Immun 1999;67: 4161-4170.
21. St Geme JW 3rd. Cutter D: Influence of pili, fibrils and capsule on in vitro adherence by Haemophilus influenzae type b. Mol Microbiol 1996;21:21-31.
22. Gilsdorf JR, Tucci M, Marrs CF: Role of pili in Haemophilus influenzae adherence to, and internalization by, respiratory cells. Pediatr Res 1996;39:343-348.
23. Drago L. Mombelli B. Fassina MC, De Vecchi E. Gismondo MR: Evaluation of antibacteria activity of cefodizine, ceftriaxone and cefonicid in Klebsiella pneumoniae infected guinea-pigs. Clin Microbiol Infect 1999;5:371-373.